Kames Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$23M Sell
736,836
-229,689
-24% -$6.94M 0.68% 50
2014
Q3
$28.6M Sell
966,525
-55,362
-5% -$1.64M 0.89% 45
2014
Q2
$30.3M Sell
1,021,887
-37,201
-4% -$1.12M 0.97% 39
2014
Q1
$34M Sell
1,059,088
-2,424,694
-70% -$76.2M 1.08% 36
2013
Q4
$107M Sell
3,483,782
-390,219
-10% -$12M 3.55% 4
2013
Q3
$111M Sell
3,874,001
-132,461
-3% -$3.8M 3.43% 3
2013
Q2
$112M Hold
4,006,462
– – 3.95% 2

Other funds holding PFE

Kames Capital Management's PFE Position: Q4 2014 in Review

Kames Capital Management reduced its Pfizer (PFE) stake by 24% in Q4 2014, selling an estimated $6.94M and leaving 736,836 shares worth $23M. The position accounts for 0.68% of the portfolio, ranked #50.

Kames Capital Management first reported a position in PFE in Q2 2013 and has held it in 7 quarters since. The position peaked at $112M in Q2 2013. 1,860 funds tracked by Wall St. Rank hold PFE as of Q4 2014.

  • Kames Capital Management held 736,836 shares of Pfizer worth $23M as of Q4 2014.
  • Kames Capital Management sold 229,689 Pfizer shares in Q4 2014, an estimated $6.94M.
  • Pfizer made up 0.68% of Kames Capital Management's portfolio in Q4 2014, its #50 holding.
  • Kames Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 7 quarters since.
  • Kames Capital Management's Pfizer position peaked at $112M in Q2 2013.
  • 1,860 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.

Based on Kames Capital Management's 13F filing for Q4 2014, filed 3 Feb 2015.